Clinical Trials Directory

Trials / Completed

CompletedNCT05229952

Assessment of Endogenous Oxalate Synthesis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
23 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.

Detailed description

Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use low-oxalate controlled diet and intravenous infusion of the isotope tracer carbon 13 oxalate, timed with blood and urine collections, to determine the daily rate of endogenous oxalate synthesis in non-stone forming volunteers and in subjects with calcium oxalate kidney stones. A DXA scan will be used to assess body composition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow-oxalate controlled dietParticipants will consume a diet that is controlled in its contents of protein, carbohydrates, fat, calcium, oxalate, vitamin C and sodium for 5 days. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them.
OTHERPrimed, continuous intravenous infusion of 13C2-oxalateParticipants will receive a continuous intravenous administration of carbon-13 oxalate, a naturally occurring form of oxalate, over the course of several hours until steady-state is achieved, using an IV catheter, while remaining fasting.

Timeline

Start date
2022-02-10
Primary completion
2024-09-09
Completion
2024-09-09
First posted
2022-02-08
Last updated
2025-05-13
Results posted
2024-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05229952. Inclusion in this directory is not an endorsement.